Erratum to "The function of IGF-IR in NNK-mediated lung tumorigenesis" [Lung Cancer 71 (1) (2011) 11-18], DOI: 10.1016/j.lungcan.2010.03.012;The function of IGF-IR in NNK-mediated lung tumorigenesis

Lung Cancer

Volumn 71, Issue 1, 2011, Pages 11-18

  Siwicky, Megan D ^a   Petrik, James J ^a   Moorehead, Roger A ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Akt; CREB; Erk1 2; IGF IR; Lung cancer; NNK

Indexed keywords

DOXYCYCLINE; NICOTINE DERIVATIVE; NITROSAMINE 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLARA CELL; CONTROLLED STUDY; GENE OVEREXPRESSION; LUNG ALVEOLUS CELL; LUNG CARCINOGENESIS; LUNG PARENCHYMA; LUNG TUMOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; TRANSGENE; TUMOR VOLUME; WILD TYPE;

EID: 78650210963     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2016.04.020     Document Type: Erratum

References (32)

1. Dubey S., Powell C.A. Update in lung cancer 2007. Am J Respir Crit Care Med 2008, 177:941-946.
2. Proctor R.N. Tobacco and the global lung cancer epidemic. Nat Rev Cancer 2001, 1:82-86.
3. Sun S., Schiller J.H., Gazdar A.F. Lung cancer in never smokers-a different disease. Nat Rev Cancer 2007, 7:778-790.
4. Hecht S.S. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 1998, 11:559-603.
5. Schrader E., Hirsch-Ernst K.I., Richter E., Foth H. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in isolated rat lung and liver. Naunyn Schmiedebergs Arch Pharmacol 1998, 357:336-343.
6. Yang Y., Zhang Z., Mukherjee A.B., Linnoila R.I. Increased susceptibility of mice lacking Clara cell 10-kDa protein to lung tumorigenesis by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a potent carcinogen in cigarette smoke. J Biol Chem 2004, 279:29336-29340.
7. Matzinger S.A., Crist K.A., Stoner G.D., Anderson M.W., Pereira M.A., Steele V.E., et al. K-ras mutations in lung tumors from A/J and A/J x TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate. Carcinogenesis 1995, 16:2487-2492.
8. Chen B., Liu L., Castonguay A., Maronpot R.R., Anderson M.W., You M. Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors. Carcinogenesis 1993, 14:1603-1608.
9. Wenzlaff A.S., Cote M.L., Bock C.H., Land S.J., Santer S.K., Schwartz D.R., et al. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study. Carcinogenesis 2005, 26:2207-2212.
10. Su T., Bao Z., Zhang Q.Y., Smith T.J., Hong J.Y., Ding X. Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res 2000, 60:5074-5079.
11. Laag E., Majidi M., Cekanova M., Masi T., Takahashi T., Schuller H.M. NNK activates ERK1/2 and CREB/ATF-1 via beta-1-AR and EGFR signaling in human lung adenocarcinoma and small airway epithelial cells. Int J Cancer 2006, 119:1547-1552.
12. Schuller H.M., Cekanova M. NNK-induced hamster lung adenocarcinomas over-express beta2-adrenergic and EGFR signaling pathways. Lung Cancer 2005, 49:35-45.
13. West K.A., Brognard J., Clark A.S., Linnoila I.R., Yang X., Swain S.M., et al. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest 2003, 111:81-90.
14. West K.A., Linnoila I.R., Belinsky S.A., Harris C.C., Dennis P.A. Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3'-kinase/Akt pathway in vitro and in vivo. Cancer Res 2004, 64:446-451.
15. Jull B.A., Plummer H.K., Schuller H.M. Nicotinic receptor-mediated activation by the tobacco-specific nitrosamine NNK of a Raf-1/MAP kinase pathway, resulting in phosphorylation of c-myc in human small cell lung carcinoma cells and pulmonary neuroendocrine cells. J Cancer Res Clin Oncol 2001, 127:707-717.
16. Quinn K.A., Treston A.M., Unsworth E.J., Miller M.J., Vos M., Grimley C., et al. Insulin-like growth factor expression in human cancer cell lines. J Biol Chem 1996, 271:11477-11483.
17. Kaiser U., Schardt C., Brandscheidt D., Wollmer E., Havemann K. Expression of insulin-like growth factor receptors I and II in normal human lung and in lung cancer. J Cancer Res Clin Oncol 1993, 119:665-668.
18. Rotsch M., Maasberg M., Erbil C., Jaques G., Worsch U., Havemann K. Characterization of insulin-like growth factor I receptors and growth effects in human lung cancer cell lines. J Cancer Res Clin Oncol 1992, 118:502-508.
19. Macaulay V.M., Teale J.D., Everard M.J., Joshi G.P., Millar J.L., Smith I.E. Serum insulin-like growth factor-I levels in patients with small cell lung cancer. Eur J Cancer Clin Oncol 1988, 24:1241-1242.
20. Baserga R., Peruzzi F., Reiss K. The IGF-1 receptor in cancer biology. Int J Cancer 2003, 107:873-877.
21. Baserga R. The IGF-I receptor in cancer research. Exp Cell Res 1999, 253:1-6.
22. Grimberg A., Cohen P. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol 2000, 183:1-9.
23. Linnerth N.M., Siwicky M.D., Campbell C.I., Watson K.L., Petrik J.J., Whitsett J.A., et al. Type I insulin-like growth factor receptor induces pulmonary tumorigenesis. Neoplasia 2009, 11:672-682.
24. Abdel-Aziz H.O., Takasaki I., Tabuchi Y., Nomoto K., Murai Y., Tsuneyama K., et al. High-density oligonucleotide microarrays and functional network analysis reveal extended lung carcinogenesis pathway maps and multiple interacting genes in NNK [4-(methylnitrosamino)-1-(3-pyridyle)-1-butanone] induced CD1 mouse lung tumor. J Cancer Res Clin Oncol 2007, 133:107-115.
25. Linnerth N.M., Baldwin M., Campbell C., Brown M., McGowan H., Moorehead R.A. IGF-II induces CREB phosphorylation and cell survival in human lung cancer cells. Oncogene 2005.
26. Hollander M.C., Balogh A.R., Liwanag J., Han W., Linnoila R.I., Anver M.R., et al. Strain-specific spontaneous and NNK-mediated tumorigenesis in Pten+/- mice. Neoplasia 2008, 10:866-872.
27. Belinsky S.A., Foley J.F., White C.M., Anderson M.W., Maronpot R.R. Dose-response relationship between O6-methylguanine formation in Clara cells and induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res 1990, 50:3772-3780.
28. Belinsky S.A., Devereux T.R., Foley J.F., Maronpot R.R., Anderson M.W. Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse. Cancer Res 1992, 52:3164-3173.
29. Dermer G.B. Origin of bronchioloalveolar carcinoma and peripheral bronchial adenocarcinoma. Cancer 1982, 49:881-887.
30. Gunning W.T., Castonguay A., Goldblatt P.J., Stoner G.D. Strain A/J mouse lung adenoma growth patterns vary when induced by different carcinogens. Toxicol Pathol 1991, 19:168-175.
31. Mason R.J., Kalina M., Nielsen L.D., Malkinson A.M., Shannon J.M. Surfactant protein C expression in urethane-induced murine pulmonary tumors. Am J Pathol 2000, 156:175-182.
32. Tsurutani J., Castillo S.S., Brognard J., Granville C.A., Zhang C., Gills J.J., et al. Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells. Carcinogenesis 2005, 26:1182-1195.